/PRNewswire/ More than 16.1 million American adults suffer from major depression. While 65% receive proper treatment, the other 35% are unable to afford any.
/PRNewswire/ Klarisana Psychedelic Therapies is pleased to announce the publication of its second case study analyzing the use of ketamine for the treatment.
/PRNewswire/ Klarisana Ketamine and Behavioral Health Center, the largest ketamine and mental health provider company in the country, introduces From Mind.